Changes in the expression of cardiac mitofusin-2 in different stages of diabetes in rats

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 811-814

  Gao, Qin ^a   Wang, Xiao Mei ^a   Ye, Hong Wei ^a   Yu, Ying ^a   Kang, Pin Fang ^a   Wang, Hong Ju ^a   Guan, Su Dong ^a   Li, Zheng Hong ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Diabetes; Mitofusin 2; Oxidative stress

Indexed keywords

CASPASE 3; GLUCOSE; MALONALDEHYDE; MESSENGER RNA; MITOFUSIN 2; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART WEIGHT; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; MALE; MALONDIALDEHYDE; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84865190222     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1002     Document Type: Article

References (19)

1. Zimmet P, Alberti KG and Shaw J: Global and societal implications of the diabetes epidemic. Nature 414: 782-787, 2001. (Pubitemid 34000780)
2. Voulgari C, Papadogiannis D and Tentolouris N: Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag 6: 883-903, 2010.
3. Bugger H and Abel ED: Mitochondria in the diabetic heart. Cardiovasc Res 88: 229-240, 2010.
4. Duncan JG: Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813: 1351-1359, 2011.
5. Huang P, Galloway CA and Yoon Y: Control of mitochondrial morphology through differential interactions of mitochondrial fusion and fission proteins. PLoS One 6: e20655, 2011.
6. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, Manco M, Calvani M, Castagneto M, Palacín M, Mingrone G, Zierath JR, Vidal H and Zorzano A: Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54: 2685-2693, 2005. (Pubitemid 41233591)
7. Tang WX, Wu WH, Zeng XX, Bo H and Huang SM: Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney. Endocrine 41: 236-247, 2012.
8. Papanicolaou KN, Khairallah RJ, Ngoh GA, Chikando A, Luptak I, O'Shea KM, Riley DD, Lugus JJ, Colucci WS, Lederer WJ, Stanley WC and Walsh K: Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol Cell Biol 31: 1309-1328, 2011.
9. Cai L and Kang YJ: Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 1: 181-193, 2001. (Pubitemid 37013746)
10. Wold LE, Ceylan-Isik AF and Ren J: Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 26: 908-917, 2005. (Pubitemid 41153210)
11. Pich S, Bach D, Briones P, Liesa M, Camps M, et al: The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14: 1405-1415, 2005. (Pubitemid 40823451)
12. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, et al: Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190-17197, 2003. (Pubitemid 36799599)
13. Chen H, Chomyn A and Chan DC: Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280: 26185-26192, 2005. (Pubitemid 41022214)
14. Wan-Xin T, Tian-Lei C, Ben W, Wei-Hua W and Ping F: Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells. J Nephrol Feb. 7, 2012 (Epub ahead of print)
15. Wang W, Lu J, Zhu F, Wei J, Jia C, Zhang Y, Zhou L, Xie H and Zheng S: Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol 29: 70-76, 2012.
16. Shen T, Zheng M, Cao C, Chen C, Tang J, Zhang W, Cheng H, Chen KH and Xiao RP: Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem 282: 23354-23361, 2007. (Pubitemid 47311963)
17. Gall JM, Wang Z, Liesa M, Molina A, Havasi A, Schwartz JH, Shirihai O, Borkan SC and Bonegio RG: Role of mitofusin 2 in the renal stress response. PLoS One 7: e31074, 2012.
18. Fang L, Moore XL, Gao XM, Dart AM, Lim YL and Du XJ: Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci 80: 2154-2160, 2007. (Pubitemid 46755331)
19. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP and Tang J: Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6: 872-883, 2004. (Pubitemid 39207252)